# Swiss SOS MoCA - DCI Study

> **NCT03032471** · — · TERMINATED · sponsor: **Swiss SOS Study Group** · enrollment: 128 (actual)

## Conditions studied

- Subarachnoid Hemorrhage
- Delayed Cerebral Ischemia
- Stroke
- Complication
- Cognitive Impairment
- Cognitive Deficit
- Cognitive Deterioration
- Cognitive Deficits Following Cerebral Infarction

## Interventions

- **OTHER:** There is no intervention for this study. Patients are allocated to the study groups based on whether or not DCI occurs.

## Key facts

- **NCT ID:** NCT03032471
- **Lead sponsor:** Swiss SOS Study Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-20
- **Primary completion:** 2022-05-06
- **Final completion:** 2022-05-06
- **Target enrollment:** 128 (ACTUAL)
- **Why stopped:** COVID-restrictions on clinical research in Switzerland
- **Last updated:** 2022-05-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03032471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03032471, "Swiss SOS MoCA - DCI Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03032471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*